secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001641172-25-014103
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharmaceuticals shareholders approve 5x increase in authorized common shares and reverse split authorization
--------------------------------------------------------------------------------

- Authorized common shares increased from 250M to 1.25B, filed June 6, 2025.
- Stockholders approved reverse stock split at ratio 1-for-2 to 1-for-100, board discretion, within one year.
- Series F and F-1 preferred stock stated value increased from $1,000 to $1,100 per share, board may increase up to $1,250.
- All six director nominees elected; auditor ratification approved.
- Voting results: ~6.3M for share increase, ~6.4M for reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000164117225014103/0001641172-25-014103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000164117225014103/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer